Annual Drug Patent Expirations for ZILXI
Zilxi is a drug marketed by Foamix and is included in one NDA. There are seven patents protecting this drug.
This drug has twenty-seven patent family members in ten countries.
The generic ingredient in ZILXI is minocycline hydrochloride. Additional details are available on the minocycline hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
